153 related articles for article (PubMed ID: 29390045)
21. Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed Mice.
Wang J; Kainrad N; Shen H; Zhou Z; Rote P; Zhang Y; Nagy LE; Wu J; You M
Am J Pathol; 2018 Aug; 188(8):1807-1819. PubMed ID: 29870742
[TBL] [Abstract][Full Text] [Related]
22. Concentration-dependent splicing is enabled by Rbfox motifs of intermediate affinity.
Begg BE; Jens M; Wang PY; Minor CM; Burge CB
Nat Struct Mol Biol; 2020 Oct; 27(10):901-912. PubMed ID: 32807990
[TBL] [Abstract][Full Text] [Related]
23. Splicing-factor alterations in cancers.
Anczuków O; Krainer AR
RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
[TBL] [Abstract][Full Text] [Related]
24. switchSENSE: A new technology to study protein-RNA interactions.
Cléry A; Sohier TJM; Welte T; Langer A; Allain FHT
Methods; 2017 Apr; 118-119():137-145. PubMed ID: 28286323
[TBL] [Abstract][Full Text] [Related]
25. Robust and annotation-free analysis of alternative splicing across diverse cell types in mice.
Benegas G; Fischer J; Song YS
Elife; 2022 Mar; 11():. PubMed ID: 35229721
[TBL] [Abstract][Full Text] [Related]
26. Interplay between coding and exonic splicing regulatory sequences.
Fontrodona N; Aubé F; Claude JB; Polvèche H; Lemaire S; Tranchevent LC; Modolo L; Mortreux F; Bourgeois CF; Auboeuf D
Genome Res; 2019 May; 29(5):711-722. PubMed ID: 30962178
[TBL] [Abstract][Full Text] [Related]
27. A Cell-Based High-Throughput Method for Identifying Modulators of Alternative Splicing.
Zheng S
Methods Mol Biol; 2017; 1648():221-233. PubMed ID: 28766300
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatics analysis of alternative splicing.
Lee C; Wang Q
Brief Bioinform; 2005 Mar; 6(1):23-33. PubMed ID: 15826354
[TBL] [Abstract][Full Text] [Related]
29. The role of alternative splicing in cancer.
Singh B; Eyras E
Transcription; 2017 Mar; 8(2):91-98. PubMed ID: 28005460
[TBL] [Abstract][Full Text] [Related]
30. CASH: a constructing comprehensive splice site method for detecting alternative splicing events.
Wu W; Zong J; Wei N; Cheng J; Zhou X; Cheng Y; Chen D; Guo Q; Zhang B; Feng Y
Brief Bioinform; 2018 Sep; 19(5):905-917. PubMed ID: 28387786
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin-c isoform levels are associated with SR and hnRNP differential expression in ovarian cancer cell lines.
Marques DS; Grativol J; Alves da Silva Peres R; da Rocha Matos A; Gimba ERP
Tumour Biol; 2017 Sep; 39(9):1010428317725442. PubMed ID: 28936921
[TBL] [Abstract][Full Text] [Related]
32. Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer.
Han J; An O; Ren X; Song Y; Tang SJ; Shen H; Ke X; Ng VHE; Tay DJT; Tan HQ; Kappei D; Yang H; Chen L
Nat Commun; 2022 Apr; 13(1):1793. PubMed ID: 35379802
[TBL] [Abstract][Full Text] [Related]
33. SRSF1-Regulated Alternative Splicing in Breast Cancer.
Anczuków O; Akerman M; Cléry A; Wu J; Shen C; Shirole NH; Raimer A; Sun S; Jensen MA; Hua Y; Allain FH; Krainer AR
Mol Cell; 2015 Oct; 60(1):105-17. PubMed ID: 26431027
[TBL] [Abstract][Full Text] [Related]
34. CircSMARCA5 Inhibits Migration of Glioblastoma Multiforme Cells by Regulating a Molecular Axis Involving Splicing Factors SRSF1/SRSF3/PTB.
Barbagallo D; Caponnetto A; Cirnigliaro M; Brex D; Barbagallo C; D'Angeli F; Morrone A; Caltabiano R; Barbagallo GM; Ragusa M; Di Pietro C; Hansen TB; Purrello M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415469
[TBL] [Abstract][Full Text] [Related]
35. Design of RNA-Binding Proteins: Manipulate Alternative Splicing in Human Cells with Artificial Splicing Factors.
Wang Y; Wang Z
Methods Mol Biol; 2016; 1421():227-41. PubMed ID: 26965269
[TBL] [Abstract][Full Text] [Related]
36. [Bioinformatics Analysis and Preliminary Functional Study of Abnormal Expression of Splicing Factors in Gastric Cancer].
Zhang A; Shi J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Jun; 42(3):289-296. PubMed ID: 32616122
[No Abstract] [Full Text] [Related]
37. Posttranscriptional Regulation of Splicing Factor SRSF1 and Its Role in Cancer Cell Biology.
Gonçalves V; Jordan P
Biomed Res Int; 2015; 2015():287048. PubMed ID: 26273603
[TBL] [Abstract][Full Text] [Related]
38. In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors.
Aktas Samur A; Fulciniti M; Avet-Loiseau H; Lopez MA; Derebail S; Corre J; Minvielle S; Magrangeas F; Moreau P; Anderson KC; Parmigiani G; Samur MK; Munshi NC
Blood Cancer J; 2022 Dec; 12(12):171. PubMed ID: 36535935
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing in lung cancer.
Coomer AO; Black F; Greystoke A; Munkley J; Elliott DJ
Biochim Biophys Acta Gene Regul Mech; 2019; 1862(11-12):194388. PubMed ID: 31152916
[TBL] [Abstract][Full Text] [Related]
40. Systematic Profile Analysis of Prognostic Alternative Messenger RNA Splicing Signatures and Splicing Factors in Head and Neck Squamous Cell Carcinoma.
Xing L; Zhang X; Tong D
DNA Cell Biol; 2019 Jul; 38(7):627-638. PubMed ID: 31025877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
